Skip to content
Inciteful Med

Symptoms, Warning Signs, and Avoiding Misdiagnosis

Last updated:

Mucopolysaccharidosis type 1 (MPS I) causes early childhood symptoms like frequent ear infections, hernias, and corneal clouding in severe cases (Hurler syndrome). Milder forms (Scheie syndrome) often present as joint stiffness without inflammation or rare childhood carpal tunnel syndrome.

Key Takeaways

  • • Severe MPS I (Hurler syndrome) symptoms typically emerge within the first 6 months of life and include hernias, frequent ear infections, and corneal clouding.
  • • Attenuated MPS I (Scheie syndrome) progresses slower and is frequently misdiagnosed as juvenile idiopathic arthritis.
  • • Joint stiffness in MPS I occurs without the heat, redness, or swelling typically seen in inflammatory arthritis.
  • • Carpal tunnel syndrome is rare in children and is a major red flag for a metabolic disorder like MPS I.
  • • Early diagnosis of MPS I is critical to begin treatments before irreversible damage occurs to the heart, joints, or nervous system.

Recognizing the symptoms of Mucopolysaccharidosis type 1 (MPS I) can be challenging because many of the early signs look like common childhood ailments. However, understanding the specific “red flags” and the typical timeline of progression can help ensure your child receives an accurate diagnosis as early as possible.

Two Different Paths: Hurler vs. Scheie

MPS I exists on a spectrum, and the speed at which symptoms appear is the primary way doctors distinguish between the severe (Hurler) and attenuated (Scheie) forms [1][2].

Severe MPS I (Hurler Syndrome): Rapid Progression

In the severe form, symptoms typically emerge within the first 6 months of life [3].

  • The First Signs: Infants may fail their newborn hearing screen or have frequent “colds,” ear infections (otitis media), and noisy breathing [3][4].
  • Physical Changes: Between 6 and 12 months, parents may notice kyphosis (a curved lower spine), an umbilical or inguinal hernia, and corneal clouding (a hazy appearance in the eyes) [3][4][5].
  • Cognitive Decline: Unlike the attenuated forms, Hurler syndrome involves a rapid, progressive decline in mental development and language skills, often becoming noticeable around 18 months of age [6][7].

Attenuated MPS I (Scheie Syndrome): The Invisible Slowdown

In attenuated (meaning milder or slower-progressing) cases, the progression is much slower, and the diagnosis is often delayed for years or even decades [8][9].

  • Slower Onset: Symptoms may not be recognized until late childhood or adolescence [6][4].
  • Mental Clarity: These children generally do not experience the rapid brain decline seen in the severe form, which often makes the underlying condition harder to spot [6][7].

Major Red Flags and Common Misdiagnoses

Because the symptoms of attenuated MPS I are often subtle, they are frequently mistaken for other more common conditions.

1. Joint Stiffness vs. Juvenile Idiopathic Arthritis (JIA)

One of the most frequent misdiagnoses for attenuated MPS I is juvenile idiopathic arthritis (JIA) [10][11]. Both conditions cause joint stiffness and reduced range of motion, but there is a key difference:

  • Non-Inflammatory: In MPS I, the stiffness is caused by the buildup of glycosaminoglycans (GAGs) in the joints, not by inflammation [12][13].
  • The Clue: If your child has stiff joints but no redness, heat, or swelling, and their blood tests for inflammation (like CRP or ESR) are normal, it may be MPS I rather than JIA [12].

2. “Quiet” Carpal Tunnel Syndrome

Carpal tunnel syndrome (CTS) is extremely rare in children. If a child is diagnosed with it, it is a major “red flag” for a metabolic disorder like MPS I [14][10][15].

  • Atypical Presentation: While adults with CTS feel numbness and tingling, children with MPS I often have “quiet” CTS [12][14]. They may simply stop using certain fingers, have difficulty with fine motor tasks, or develop a “claw hand” appearance [12][13].
  • Monitoring: Because permanent nerve damage can occur without the child complaining of pain, annual nerve conduction studies are recommended starting at age 3 [16][10].

3. Multisystem Symptoms

Unlike JIA or simple carpal tunnel, MPS I is a “multisystem” disorder [1][17]. If your child has joint issues along with other symptoms—such as a heart valve murmur, hernias, or frequent respiratory infections—it is a strong signal to test for MPS I [12][18].

Why Early Detection Matters

The goal of identifying these warning signs is to avoid the “diagnostic odyssey” that many families face, which can last an average of nearly 3 years [11]. Early diagnosis allows for life-altering treatments to begin before irreversible damage occurs to the heart, joints, or nervous system [2][6].

Frequently Asked Questions

What are the earliest signs of severe MPS I (Hurler syndrome)?
In the first six months of life, infants may fail hearing screens, have frequent ear infections, or experience noisy breathing. By 12 months, parents might notice a curved lower spine, hernias, or a cloudy appearance in the eyes.
How is MPS I joint stiffness different from juvenile arthritis?
Joint stiffness in MPS I is caused by a buildup of complex sugars in the tissue, not by inflammation. Unlike arthritis, joints affected by MPS I are stiff but typically do not have the redness, heat, or swelling seen in inflammatory conditions.
Why is carpal tunnel syndrome in a child a warning sign for MPS I?
Carpal tunnel syndrome is extremely rare in young children. If a child develops it, especially a quiet form without obvious pain but with difficulty performing fine motor tasks, it is a strong red flag for an underlying metabolic disorder like MPS I.
What is the difference between Hurler and Scheie syndromes?
Hurler syndrome is the severe form of MPS I, featuring rapid physical symptoms and cognitive decline starting in infancy. Scheie syndrome is the milder form, where symptoms progress much slower and cognitive function is generally preserved.
How do doctors monitor for carpal tunnel if a child isn't complaining of pain?
Children with MPS I can develop permanent nerve damage without feeling typical numbness or tingling. Doctors recommend starting annual nerve conduction studies around age 3 to proactively monitor for quiet carpal tunnel syndrome.

Questions for Your Doctor

  • • Given that carpal tunnel syndrome is rare in children, does my child's diagnosis of it point specifically toward MPS I?
  • • If my child has joint stiffness but no inflammation, does that help rule out juvenile idiopathic arthritis and point toward a metabolic condition?
  • • What are the 'red flag' symptoms I should look for that might indicate my child's condition is moving from attenuated to a more severe form?
  • • How do we monitor for 'quiet' carpal tunnel syndrome if my child isn't complaining of numbness or tingling?
  • • At what age should we begin annual nerve conduction studies to prevent permanent nerve damage?

Questions for You

  • • Did my child have any hernias or frequent ear infections in their first year of life?
  • • When my child has joint pain, is there also swelling, redness, or heat, or is it just stiff?
  • • Is my child having difficulty with 'fine motor' tasks like buttoning a shirt or picking up small objects?
  • • Have I noticed any cloudiness or haziness in my child's eyes when the light hits them a certain way?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.

    Clarke LA, Giugliani R, Guffon N, et al.

    Clinical genetics 2019; (96(4)):281-289 doi:10.1111/cge.13583.

    PMID: 31194252
  2. 2

    Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.

    Hampe CS, Wesley J, Lund TC, et al.

    Biomolecules 2021; (11(2)) doi:10.3390/biom11020189.

    PMID: 33572941
  3. 3

    Early disease progression of Hurler syndrome.

    Kiely BT, Kohler JL, Coletti HY, et al.

    Orphanet journal of rare diseases 2017; (12(1)):32 doi:10.1186/s13023-017-0583-7.

    PMID: 28193245
  4. 4

    Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.

    Jameson E, Jones S, Remmington T

    The Cochrane database of systematic reviews 2016; (4()):CD009354 doi:10.1002/14651858.CD009354.pub4.

    PMID: 27033167
  5. 5

    Mucopolysaccharidosis type I due to maternal uniparental disomy of chromosome 4 with partial isodisomy of 4p16.3p15.2.

    Katja K, Inga V, Ramona L, et al.

    Molecular genetics and metabolism reports 2020; (25()):100660 doi:10.1016/j.ymgmr.2020.100660.

    PMID: 33117653
  6. 6

    18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I.

    Pjetraj D, Santoro L, Sgattoni C, et al.

    American journal of medical genetics. Part A 2023; (191(2)):564-569 doi:10.1002/ajmg.a.63029.

    PMID: 36333985
  7. 7

    MPS I: Early diagnosis, bone disease and treatment, where are we now?

    Kingma SDK, Jonckheere AI

    Journal of inherited metabolic disease 2021; (44(6)):1289-1310 doi:10.1002/jimd.12431.

    PMID: 34480380
  8. 8

    Progressive Hand Stiffness and Numbness in a Child: An Atypical Neurological Presentation of Scheie Syndrome-A Case Report.

    Alharthi AS, Hassan CI, Alsharkawy AA, et al.

    Neurology international 2025; (17(12)) doi:10.3390/neurolint17120205.

    PMID: 41441225
  9. 9

    Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I.

    Giugliani R, Muschol N, Keenan HA, et al.

    Archives of disease in childhood 2021; (106(7)):674-679 doi:10.1136/archdischild-2020-319040.

    PMID: 33139350
  10. 10

    Carpal tunnel syndrome in mucopolysaccharidosis I: a registry-based cohort study.

    Viskochil D, Muenzer J, Guffon N, et al.

    Developmental medicine and child neurology 2017; (59(12)):1269-1275 doi:10.1111/dmcn.13545.

    PMID: 28892147
  11. 11

    The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences.

    Bruni S, Lavery C, Broomfield A

    Molecular genetics and metabolism reports 2016; (8()):67-73 doi:10.1016/j.ymgmr.2016.07.006.

    PMID: 27536552
  12. 12

    Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of Scheie syndrome: Three cases from the same family.

    Gökay S, Kardaş F, Kendirci M, Sözeri B

    The Turkish journal of pediatrics 2018; (60(3)):344-347.

    PMID: 30511553
  13. 13

    Carpal tunnel syndrome in mucopolysaccharidosis type I: clinical, surgical and histopathological findings.

    van Binsbergen BAW, van Dongen JA, Vriend L, et al.

    The Journal of hand surgery, European volume 2026; 17531934261416366 doi:10.1177/17531934261416366.

    PMID: 41656624
  14. 14

    Carpal tunnel syndrome in children: a case report.

    Ali SM, Youssef BO, Senda B, et al.

    The Pan African medical journal 2022; (41()):116 doi:10.11604/pamj.2022.41.116.33182.

    PMID: 35465368
  15. 15

    [Median nerve compression in the carpal tunnel in children - a delayed diagnosis. About 20 clinical cases].

    Andre E, Hamel A, Perrot P, Duteille F

    Annales de chirurgie plastique et esthetique 2021; (66(4)):298-304 doi:10.1016/j.anplas.2021.04.003.

    PMID: 34144846
  16. 16

    The Association Between Concomitant Ulnar Nerve Compression at the Elbow and Carpal Tunnel Syndrome.

    Shulman B, Bekisz J, Lopez C, et al.

    Hand (New York, N.Y.) 2020; (15(3)):335-340 doi:10.1177/1558944718813669.

    PMID: 30499347
  17. 17

    Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.

    Sato Y, Fujiwara M, Kobayashi H, et al.

    Molecular genetics and metabolism reports 2015; (5()):94-97 doi:10.1016/j.ymgmr.2015.10.014.

    PMID: 28649551
  18. 18

    Hurler-Scheie syndrome in Niger: a case series.

    Assadeck H, Toudou Daouda M, Bako H, Hassane Djibo F

    Journal of medical case reports 2019; (13(1)):102 doi:10.1186/s13256-019-2047-2.

    PMID: 31018863

This page provides educational information about MPS I symptoms and warning signs. It does not replace professional medical advice. Always consult a pediatrician or genetic specialist if you have concerns about your child's development.

Stay up to date

Get notified when new research about Mucopolysaccharidosis type 1 is published.

No spam. Unsubscribe anytime.